Status:
TERMINATED
Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea
Lead Sponsor:
University of Zurich
Conditions:
Atrial Fibrillation
Sleep Apnea, Obstructive
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
There is accumulating evidence for obstructive sleep apnea (OSA) as an independent risk factor for paroxysmal atrial fibrillation and for high recurrence rates of atrial fibrillation after ablation th...
Eligibility Criteria
Inclusion
- History of ECG-documented paroxysmal atrial fibrillation within the last 12 months and currently in sinus rhythm
- Scheduled for circumferential pulmonary venous isolation treatment
- 18 to 75 years of age
- Signed informed consent
Exclusion
- Treated with class III anti-arrhythmic agents (at the moment of pulmonary venous isolation)
- Treated for obstructive sleep apnea
- Previous catheter ablation in the pulmonary veins or left atrium
- Severe structural heart disease
- Mental or physical disability precluding informed consent or compliance with the protocol
- Enrolled in another study that would confound the results of this trial
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT02269774
Start Date
September 1 2014
End Date
January 1 2016
Last Update
October 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Zurich
Zurich, Canton of Zurich, Switzerland, 8091